Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00055250
What this trial is testing

A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eli Lilly and Company 130
Early research (Phase 1)Not Yet RecruitingNCT06346808
What this trial is testing

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

Who this might be right for
Pancreatic Cancer
Sichuan University 20
Testing effectiveness (Phase 2)Ended earlyNCT04383210
What this trial is testing

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid TumorPancreatic Cancer+14 more
Elevation Oncology 54
Early research (Phase 1)Looking for participantsNCT06141031
What this trial is testing

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Washington University School of Medicine 24
Testing effectiveness (Phase 2)Study completedNCT00602602
What this trial is testing

Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Abramson Cancer Center at Penn Medicine 19
Early research (Phase 1)Study completedNCT00033241
What this trial is testing

Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Pancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
OSI Pharmaceuticals
Early research (Phase 1)Ended earlyNCT00310050
What this trial is testing

Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Wake Forest University Health Sciences 4
Testing effectiveness (Phase 2)Study completedNCT00049348
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Not applicableLooking for participantsNCT06984562
What this trial is testing

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA)
Fox Chase Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT03599362
What this trial is testing

Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NYU Langone Health 7
Testing effectiveness (Phase 2)Ended earlyNCT03127098
What this trial is testing

QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer

Who this might be right for
Thyroid CancerColon CancerOvarian Cancer+3 more
NantCell, Inc. 3
Testing effectiveness (Phase 2)Looking for participantsNCT06831136
What this trial is testing

Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The University of Texas Health Science Center, Houston 24
Not applicableUnknownNCT03964064
What this trial is testing

I125 Seed Implantation vs Stereotactic Radiotherapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableBrachytherapyRadiotherapy
Peking University Third Hospital 100
Early research (Phase 1)Ended earlyNCT02110563
What this trial is testing

Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma

Who this might be right for
Solid TumorsMultiple MyelomaNon-Hodgkins Lymphoma+3 more
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07108504
What this trial is testing

Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerChemotherapy Effect
Shanghai Zhongshan Hospital 30
Not applicableLooking for participantsNCT06944587
What this trial is testing

A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CancerBorderline Resectable Pancreatic CancerPancreatectomy+1 more
Oslo University Hospital 400
Early research (Phase 1)WithdrawnNCT07488884
What this trial is testing

Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer ResectablePancreatic Cancer
ImmunityBio, Inc.
Early research (Phase 1)Looking for participantsNCT07094204
What this trial is testing

Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Who this might be right for
Solid TumorNon-Small-Cell Lung CancerPancreatic Ductal Adenocarcinoma+1 more
Astellas Pharma Inc 364
Testing effectiveness (Phase 2)WithdrawnNCT00226746
What this trial is testing

Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
New York Presbyterian Brooklyn Methodist Hospital
Testing effectiveness (Phase 2)Study completedNCT02707159
What this trial is testing

Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients

Who this might be right for
Metastatic Pancreatic Cancer
Helse Stavanger HF 70
Next Page